Surgical treatment of basal cell carcinoma and squamous cell carcinoma

被引:0
|
作者
Gualdi, G. [1 ]
Monari, P. [1 ]
Apalla, Z. [2 ]
Lallas, A. [3 ]
机构
[1] Spedali Civili Brescia, Dermatol Clin, I-25123 Brescia, Italy
[2] State Clin Dermatol, Hosp Skin & Venereal Dis, Thessaloniki, Greece
[3] Arcispedale Santa Maria Nuova, Dermatol & Skin Canc Unit, IRCCS, Reggio Emilia, Italy
来源
关键词
Skin neoplasms; Surgical procedures; operative; Carcinoma; basal cell; squamous cell; FREE-TISSUE TRANSFER; MOHS MICROGRAPHIC SURGERY; PURSE-STRING SUTURE; SKIN SUBSTITUTES; DERMATOLOGICAL SURGERY; CIGARETTE-SMOKING; RECONSTRUCTION; EXCISION; MARGINS; FLAPS;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Non melanoma skin cancers (NMSC) are the most common human neoplasms, encompassing basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), but also cutaneous lymphomas, adnexal tumors, merckel cell carcinoma and other rare tumors. The incidence of BCC and SCC varies significantly among different populations, and the overall incidence of both tumors has increased over the last decades. Although generally associated with a favorable prognosis, recent evidence suggests that the mortality rates of SCC might have been underestimated up-to-date.(1) According to Medicare data, NMSC is the fifth most expensive cancer for health care systems. This increased economic burden is not associated with the cost of treating an individual patient, but with the large number of affected patients and the recurrence rates.(2) Therefore, the adequate management of the primary tumor with a complete excision becomes a priority not only for the patient but also for the public health systems. Multiple treatment modalities are currently usedin clinicalpractice for the treatment of NMSC. While surgical excision (SE) remains the gold standard of care, non-surgical techniques have gained appreciation due to lower morbidity and better cosmetic results. The optimal management of treatment includes a complete tumor clearance, preservation of the normal tissue function, and the best possible cosmetic outcome.(3) Surgery with a predefined excision margin is the treatment of choice for most NMSCs, with Mohs micrographic surgery being recommended for tumors considered to be at a higher recurrence risk or those developing on cosmetically sensitive areas.(4,5) Therefore, the surgical approach of a NMSC consists with three different and equally important steps. First the preoperative clinical assessment of the tumor margins, which can be facilitated by the use of dermoscopy. Second, the definition of the surgical margins depending on the tumor subtype and its biological behavior. Finally, the surgical procedure must be designed based on the anatomic site and the patient's charachteristics. This preoperative assessment requires specific skills and might be performed by a physician, the dermatosurgeon, two collaborating specialists, namely a dermatologist and a surgeon.
引用
收藏
页码:435 / 447
页数:13
相关论文
共 50 条
  • [41] BASAL CELL EPITHELIOMA AND SQUAMOUS CELL CARCINOMA IN ANIMALS
    MULLER, GH
    ARCHIVES OF DERMATOLOGY, 1967, 96 (04) : 386 - +
  • [42] Intralesional interferon α-2b in the treatment of basal cell carcinoma and squamous cell carcinoma:: Revisited
    Kim, KH
    Yavel, RM
    Gross, VL
    Brody, N
    DERMATOLOGIC SURGERY, 2004, 30 (01) : 116 - 120
  • [43] Tumor Recurrence 5 Years after Treatment of Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
    Chren, Mary-Margaret
    Linos, Eleni
    Torres, Jeanette S.
    Stuart, Sarah E.
    Parvataneni, Rupa
    Boscardin, W. John
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (05) : 1188 - 1196
  • [44] Immunohistochemical Analysis of Sebaceous Cell Carcinoma in Comparison to Both Basal Cell Carcinoma and Squamous Cell Carcinoma
    Ali-Ridha, Andre Nihad
    Brownstein, Seymour
    Jiang, Kailun
    Milman, Tatyana
    Burns, Bruce
    Blanco, Paula
    Farmer, James
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [45] The Efficacy of Photodynamic Therapy in Treatment of Recurrent Squamous Cell and Basal Cell Carcinoma
    Farhadi, Mohammad
    Kamrava, Seyed Kamran
    Behzadi, Ashkan Heshmatzade
    Rafiezadeh, Parviz
    Asghari, Ahmohamad
    Rezvan, Farhad
    Maleki, Shayan
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (02) : 122 - 126
  • [46] Actinic keratoses, basal cell carcinoma, and squamous cell carcinoma: uncommon treatments
    Russo, GG
    CLINICS IN DERMATOLOGY, 2005, 23 (06) : 581 - 586
  • [47] Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age
    Chahal, Harvind S.
    Rieger, Kerri E.
    Sarin, Kavita Y.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (02) : 353 - +
  • [48] INTERFERON THERAPY FOR BASAL-CELL CARCINOMA AND SQUAMOUS-CELL CARCINOMA
    IKIC, D
    PADOVAN, I
    PIPIC, N
    KNEZEVIC, M
    DJAKOVIC, N
    RODE, B
    KOSUTIC, I
    BELICZA, M
    CAJKOVAC, V
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1991, 29 (09) : 342 - 346
  • [49] Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma
    Lichter, MD
    Karagas, MR
    Mott, LA
    Spencer, SK
    Stukel, TA
    Greenberg, ER
    ARCHIVES OF DERMATOLOGY, 2000, 136 (08) : 1007 - 1011
  • [50] Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma
    Scott, Glynis A.
    Laughlin, Todd S.
    Rothberg, Paul G.
    MODERN PATHOLOGY, 2014, 27 (04) : 516 - 523